FI  CAM Capital

     Office Locations:

1330 Sixth Avenue, Floor 20
New York, NY 10019
Phone: 212-205-6800



  • Middle Market



  • Business Services
  • Manufacturing & Industrial



    CAM Capital was established in 2012 by Bruce Kovner following his retirement from Caxton Associates, the macro hedge fund he founded and managed from 1983 to 2011. CAM Capital manages assets exclusively for entities related to Mr. Kovner and its senior employees. Kovner is estimated by Forbes to be worth $5B. CAM Capital's goal is to achieve long-term compounded growth of its portfolio using a diversified, opportunistic investment strategy. In pursuit of this goal, CAM Capital engages in both trading activities and fundamentally driven investments. The firm's investments span all parts of the corporate capital structure in both the private and public markets. CAM's geographic focus is primarily in the Americas and Western Europe. CAM invests both independently and in collaboration with like-minded external partners. The firm favors a sector-agnostic approach, with a focus on special situations. While CAM's approach focuses on direct investments, the firm will partner with select external managers.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bruce Kovner Chairman
    David Ben-Ur Chief Investment Officer
    Heath Weisberg General Counsel
    Karen Cross COO and CFO
    Peter D'Angelo President


    Recent Funding Events (trailing 12 months):







      Antios Therapeutics



      Series A


    Portfolio companies include:


    Recent News: